measuregroup/AID1799330

Predicate	Object
has specified output	http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID85856459_AID1799330_PMID19900813_VALUE1 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID85856463_AID1799330_PMID19900813_VALUE4 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID85856464_AID1799330_PMID19900813_VALUE5 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID85856461_AID1799330_PMID19900813_VALUE2 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID85856465_AID1799330_PMID19900813_VALUE6 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID85856462_AID1799330_PMID19900813_VALUE3
has participant	http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP30518
source	http://rdf.ncbi.nlm.nih.gov/pubchem/source/BindingDB
title	Binding Assay for Human V2 Receptor from Article 10.1016/j.bmc.2009.10.038: \"Optimization of (4,4-difluoro-1,2,3,4-tetrahydro-5H-1-benzazepine-5-ylidene)acetamide derivatives as arginine vasopressin V2 receptor agonists and discussion of their binding modes.\"
type	http://www.bioassayontology.org/bao#BAO_0000040

Predicate	Subject
participates in	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID85856459 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID85856464 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID85856463 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID85856461 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID85856465 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID85856462
has measure group	http://rdf.ncbi.nlm.nih.gov/pubchem/bioassay/AID1799330

Total number of triples: 17.